Thursday Feb 9 | AmericanBankingNews.com
Zacks Investment Research Analysts Upgrade ICON plc Shares to "Neutral"
ICON plc was upgraded by Zacks Investment Research from an "underperform" rating to a "neutral" rating in a research note issued to investors on Thursday.
Taking Advantage of Europe's Pain
The bear market on the continent discounted at least two tempting bargains, says Morningstar equities strategist Michael Tian in this exclusive interview.
VirtualScopics, PPD Expand Ties - Analyst Blog
Medical imaging solution provider VirtualScopics has expanded its strategic collaboration with North Carolina-based leading contract research organization Pharmaceutical Product Development Inc.
ICON Strengthens Global Scientific Council With the Appointments of and
Dublin, Ireland, January 24, 2012 - ICON plc , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Professor Brendan Buckley and Dr.
Also on Topix